DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin: Dysferlinopathy phenotypes include progressive atrophy of limb muscles, elevated serum creatine kinase levels, reduced expression of plasmalemmal dysferlin, and prevalence of immature muscle fibers [17,18].